M, M., H, U. K., MI, K., I, K., RM, A., S, H., & YM, Y. (2022). Trajectory of anti-SARS-COV-2 IgG antibodies from onset of symptoms to 6 months in a cohort of Pakistani patients. Infectious diseases (London, England), 54(6), 460. https://doi.org/10.1080/23744235.2022.2033312
Chicago Style (17th ed.) CitationM, Mehmood, Usman Khan H, Khan MI, Khan I, Al-Raddadi RM, Harakeh S, and Yousafzai YM. "Trajectory of Anti-SARS-COV-2 IgG Antibodies from Onset of Symptoms to 6 Months in a Cohort of Pakistani Patients." Infectious Diseases (London, England) 54, no. 6 (2022): 460. https://doi.org/10.1080/23744235.2022.2033312.
MLA (9th ed.) CitationM, Mehmood, et al. "Trajectory of Anti-SARS-COV-2 IgG Antibodies from Onset of Symptoms to 6 Months in a Cohort of Pakistani Patients." Infectious Diseases (London, England), vol. 54, no. 6, 2022, p. 460, https://doi.org/10.1080/23744235.2022.2033312.